SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 321.15 |
| Enterprise Value ($M) | 476.84 |
| Book Value ($M) | -28.45 |
| Book Value / Share | -0.19 |
| Price / Book | -11.29 |
| NCAV ($M) | -51.36 |
| NCAV / Share | -0.34 |
| Price / NCAV | -6.25 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.05 |
| Return on Assets (ROA) | -0.04 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.76 |
| Current Ratio | 2.40 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 212.84 |
| Assets | 235.75 |
| Liabilities | 264.20 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 144.28 |
| Operating Income | -11.53 |
| Net Income | -13.58 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -22.53 |
| Cash from Investing | 18.71 |
| Cash from Financing | 0.94 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Adage Capital Management, L.P. | 5.84 | ||
| 13G | BlackRock, Inc. | 5.60 | 0.00 | |
| 13D/A | Rubric Capital Management LP | 17.70 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 328,474 | 1,641,975 | 20.00 | |
| 397,232 | 1,526,113 | 26.03 | |
| 451,432 | 2,000,193 | 22.57 | |
| 1,480,175 | 7,149,575 | 20.70 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| HEPA – Hepion Pharmaceuticals, Inc. | HOOK – HOOKIPA Pharma Inc. |
| HOTH – Hoth Therapeutics, Inc. | IBIO – iBio, Inc. |
| ICCC – ImmuCell Corporation |